LSD Breakthrough, Bitcoin Self Custody, and Uranium Explorer M&A

LSD Receives Breakthrough Therapy Designation From FDA

MindMed (NASDAQ:MNMD) has received a Breakthrough Therapy designation from the United States FDA for their novel drug MM120 for General Anxiety Disorder, marking the first such designation for an LSD-derived therapeutic. New clinical trial data from MindMed showed that 48% of patients went into remission from General Anxiety Disorder after just 1 dose of MM120.

Disrupting Bitcoin Ownership With Streamlined Self-Custody

Bitcoin Well (TSXV:BTCW) has been experiencing rapid growth for their non-custodial Bitcoin platform for North American users, adding over 1,200 new users to their platform in February and surpassing over 13,000 unique users in total. The company’s technology infrastructure acts as an on-ramp for users to be able to purchase Bitcoin that is then directly sent to their own digital asset wallet instantaneously.

Uranium Explorers Are Teaming Up

ATHA Energy (TSXV:SASK) has officially acquired Latitude Uranium (CSE:LUR). The move adds multiple new properties with a collective resource estimate of 57.8 million pounds of uranium to ATHA’s existing land package of over 6.5 million acres in the Athabasca and Thelon Basins.

The Sprint

• The US Department of Energy has launched a $4 million competition to help incubate new technologies for recovering critical materials from electronic waste.

• Glacier raised $7.7 million in new funding to advance their AI-powered robots that are capable of rapidly sorting recycled materials.

• MethaneSAT officially launched into orbit, where it will use satellite imaging technology to identify methane leaks, particularly from oil and gas infrastructure.

Trending Now

• Sweden Takes A Fresh Look At Uranium

• Chevron Joins The Hydrogen Race

• Solar Energy Startups Are On The Rise

New here? Join our community of 25,000+ individuals interested in uncovering the world’s most exciting early stage companies.